Phase 2 study of selinexor in patients with myelodysplastic syndromes refractory to hypomethylating agents: Interim report Meeting Abstract
| Authors: | Klimek, V. M.; Coleman, M.; Alvarez, K.; Sen, F.; Pichardo, J.; Kashyap, T.; Klebanov, B. |
| Abstract Title: | Phase 2 study of selinexor in patients with myelodysplastic syndromes refractory to hypomethylating agents: Interim report |
| Meeting Title: | 14th International Symposium on Myelodysplastic Syndromes (MDS) |
| Journal Title: | Leukemia Research |
| Volume: | 55 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 May 3-6 |
| Meeting Location: | Valencia, Spain |
| ISSN: | 0145-2126 |
| Publisher: | Elsevier Ltd |
| Date Published: | 2017-04-01 |
| Start Page: | S32 |
| Language: | English |
| ACCESSION: | WOS:000417653300048 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0145-2126(17)30160-1 |
| Notes: | Meeting Abstract: 47 -- 14th International Symposium on Myelodysplastic Syndromes (MDS) -- MAY 03-06, 2017 -- Valencia, SPAIN -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
